EUCTR2004-001586-18-GB进行中（未招募）不适用
A Safety Study of TDS-943
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Subject is cleared by a site-affiliated physician.
- •- Unremarkable EGD at baseline.
- •- healthy man or woman between 18 - 55 years of age.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Active GI disease, Chronic or Acute renal or hepatic disorder;
- •- history of any hypersensitivity (including asthma, rhinitis, or urticaria) to diclofenac
- •or to any of the excipients used in the topical spray, or to celecoxib, naproxen
- •or to aspirin or any other NSAID, or to paracetamol;
- •- testing Positive for H.Pylori
- •- any skin disorder/wound at the application site
研究者
相似试验
进行中（未招募）
不适用
TDS-943 MAXIMUM USE TOLERANCE STUDYRelieve pain and swelling in joints, musclesEUCTR2004-000035-28-GBWyeth Consumer Healthcare75
已完成
4 期
A clinical trial to study the effects of drug in pediatric subjects with complicated Skin & skin structure infection caused by Gram-positive PathogensCTRI/2009/091/000725Cubist Pharmaceuticals150
已完成
不适用
A verification study of safety evaluation of the test food long-term administration in humans: a randomized, double-blind, placebo-controlled, parallel studyHealthy Japanese subjectsJPRN-UMIN000032641ORTHOMEDICO Inc.30
尚未招募
1 期
Phase 1 Safety study for thyroid healthCTRI/2019/03/017887The Himalaya Drug Company
未知
1 期
Phase I study of DS-7113bHealthy volunteersJPRN-jRCT2080222121DAIICHISANKYO Co.,Ltd.30